si-b001
Showing 1 - 10 of 10
NSCLC Trial in Shanghai (SI-B001, SI-B003)
Not yet recruiting
- Non-small Cell Lung Cancer
- SI-B001
- SI-B003
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Jul 10, 2023
Squamous Cell Carcinoma of Head and Neck Trial in Shanghai (SI-B001, SI-B003)
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- SI-B001
- SI-B003
-
Shanghai, Shanghai, ChinaShanghai Oriental Hospital
Jan 13, 2023
Non-small Cell Lung Adenocarcinoma, Squamous Cell Carcinoma of Lung Trial in Guangzhou (SI-B001, Docetaxel)
Not yet recruiting
- Non-small Cell Lung Adenocarcinoma
- Squamous Cell Carcinoma of Lung
- SI-B001
- Docetaxel
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Jul 5, 2023
NSCLC Trial in Guangdong (SI-B001, Osimertinib)
Recruiting
- Non-small Cell Lung Cancer
- SI-B001
- Osimertinib
-
Guangdong, Guangzhou, ChinaSun Yat-sen University Cancer Center (SYSUCC)
Jul 31, 2022
Locally Advanced or Metastatic Epithelial Tumor Trial in Guangzhou (SI-B001)
Active, not recruiting
- Locally Advanced or Metastatic Epithelial Tumor
- SI-B001
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Mar 14, 2022
Esophageal Squamous Cell Carcinomas Trial in Beijing (SI-B001, Irinotecan)
Recruiting
- Esophageal Squamous Cell Carcinomas
- SI-B001
- Irinotecan
-
Beijing, Beijing, ChinaBeijing Cancer Hostital
Mar 14, 2022
Head and Neck Squamous Cell Carcinoma Trial in Shanghai (SI-B001, Paclitaxel)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- SI-B001
- Paclitaxel
-
Shanghai, Shanghai, ChinaShanghai Oriental Hospital
Mar 3, 2022
Non Small Cell Lung Cancer Trial in Guangzhou (SI-B001, AP or TP, Docetaxel)
Recruiting
- Non Small Cell Lung Cancer
- SI-B001
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center (SYSUCC)
Mar 14, 2022
Colorectal Cancer Trial in Shanghai (SI-B001, Irinotecan, FOLFIRI Protocol)
Recruiting
- Colorectal Cancer
- SI-B001
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Dec 16, 2021
Head and Neck Squamous Cell Carcinoma Trial in Shanghai (SI-B001)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- SI-B001
-
Shanghai, Shanghai, ChinaShanghai Oriental Hospital
Dec 16, 2021